NS-2331

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNS-2331
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionSerotonin reuptake inhibitorsPolyamine uptake inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurosearch As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurosearch As
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A